Pituitary suppression regimens in poor responders undergoing IVF treatment: a systematic review and meta-analysis

Akman, 2001, Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial, Human Reproduction, 16, 868, 10.1093/humrep/16.5.868 Akman, 2000, Addition of GnRH antagonist in cycles of poor responders undergoing IVF, Human Reproduction, 15, 2145, 10.1093/humrep/15.10.2145 Cheung, 2005, GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial, Human Reproduction, 20, 616, 10.1093/humrep/deh668 Crammer, 1999, Gonadotrophin-releasing hormone agonist use in assisted reproduction cycles: the influence of long and short regimens on pregnancy rates, Fertility and Sterility, 72, 83, 10.1016/S0015-0282(99)00187-9 CRD 2001 CRD Report Number 4, 2nd Edition. Undertaking Systematic Reviews of Research on Effectiveness. CRD's Guidance For Carrying Out of Commissioning Reviews. NHS Center for Reviews and Dissemination, University of York. Daya, 1997, Optimal protocol for gonadotrophin-releasing hormone agonist use in ovarian stimulation, 405 De Placido, 2006, Gonadotropin-releasing hormone (GnRH) antagonist plus recombinant luteinizing hormone vs. a standard GnRH agonist short protocol in patients at risk for poor ovarian response, Fertility and Sterility, 85, 247, 10.1016/j.fertnstert.2005.07.1280 Dirnfeld, 1999, Cessation of gonadotrophin-releasing hormone analogue (GnRH-a) upon down-regulation versus conventional long GnRH-a protocol in poor responders undergoing in vitro fertilization, Fertility and Sterility, 72, 406, 10.1016/S0015-0282(99)00289-7 Faber, 1998, Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders, Fertility and Sterility, 69, 826, 10.1016/S0015-0282(98)00040-5 Garcia, 1990, Follicular phase gonadotrophin releasing hormone agonist and human gonadotrophins: a better alternative for in vitro fertilization, Fertility and Sterility, 53, 302, 10.1016/S0015-0282(16)53285-3 Garcia-Velasco, 2000, High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients: a prospective, randomized controlled trial, Human Reproduction, 15, 2292, 10.1093/humrep/15.11.2292 Griesinger, 2004, Gonadotropin-releasing hormone antagonists for assisted reproductive techniques. Are there clinical differences between agents?, Drugs, 64, 563, 10.2165/00003495-200464060-00001 Hugues, 1998, Revisiting gonadotrophin-releasing hormone agonist protocols and management of poor ovarian responses to gonadotrophins, Human Reproduction Update, 4, 83, 10.1093/humupd/4.1.83 Keay, 1997, Assisted conception following poor ovarian response to gonadotrophin stimulation, British Journal of Obstetrics and Gynaecology, 104, 521, 10.1111/j.1471-0528.1997.tb11525.x Kenigsberg, 1984, Medical hypophysectomy: 1. Dose-response using a gonadotrophin-releasing hormone antagonist ganirelix for in vitro fertilization cycles in which the lead follicle is >14 mm, Fertility and Sterility, 42, 112, 10.1016/S0015-0282(16)47968-9 Klingmuller, 1993, Hormonal responses to new potent GnRH antagonist cetrorelix, Acta Endocrinologica, 128, 15, 10.1530/acta.0.1280015 Lashen, 1999, Management of poor responders, Human Reproduction, 14, 1919, 10.1093/humrep/14.7.1919 Mahutte, 2002, Poor responders: does the protocol make a difference?, Current Opinion in Obstetrics and Gynaecology, 14, 275, 10.1097/00001703-200206000-00005 Malmusi, 2005, Comparison of a gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare-up regimen in poor responders undergoing ovarian stimulation, Fertility and Sterility, 84, 402, 10.1016/j.fertnstert.2005.01.139 Marci, 2005, GnRH antagonist in IVF poor-responder patients: results of a randomized trial, Reproductive BioMedicine Online, 11, 189, 10.1016/S1472-6483(10)60957-1 Morgia, 2004, A controlled trial of natural cycle versus microdose gonadotrophin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization, Fertility and Sterility, 81, 1542, 10.1016/j.fertnstert.2003.11.031 Schmidt, 2005, A randomized prospective study of microdose leuprolide versus ganirelix in in vitro fertilization cycles for poor responders, Fertility and Sterility, 83, 1568, 10.1016/j.fertnstert.2004.10.053 Shanbhag S, Aucott L, Bhattacharya S et al. 2007 Interventions for ‘poor responders’ to controlled ovarian hyperstimulation (COH) in in-vitro fertilisation (IVF). Cochrane Database of Systematic Reviews. Issue1: Art No.: CD004379. DOI:10.1002/14651858.CD004379.pub2. Surrey, 2003, Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques, Fertility and Sterility, 73, 667, 10.1016/S0015-0282(99)00630-5 Weissman, 2003, Prospective evaluation of two stimulation protocols for low responders who were undergoing in vitro fertilization-embryo transfer, Fertility and Sterility, 79, 886, 10.1016/S0015-0282(02)04928-2